Uruguay approves vaccination against covid-19 for children between 5 and 11 years old

This content was published on 24 November 2021 – 19:25

Montevideo, Nov 24 (EFE) .- Uruguay today approved the vaccination against covid-19 for children between five and 11 years old “in a staggered manner”, which will begin with the groups considered at risk.

This was announced by the Ministry of Public Health (MSP) of the country in a statement, in which it details that the resolution was taken after a meeting of the National Vaccine Advisory Commission and the group created “ad hoc”, with the presence of teachers of pediatric clinics of the Faculty of Medicine of the University of the Republic.

“This advisory team unanimously recommends: – Advance in the extension of vaccination against covid-19 in girls and boys from 5 to 11 years old, not compulsory, in a phased manner. This vaccination will begin in risk groups, on the date of define “, details the writing.

Likewise, the text states that “the emerging evidence review process will continue” and the recommendation will be updated as the evidence evolves.

“According to the best current evidence available, this technical group, by majority, recommends the Pfizer / BioNtech mRNA vaccine,” he says.

On the other hand, the statement emphasizes that this inoculation will be voluntary and that it should not imply “a limitation” in this age group to carry out “any type of activity that involves them” in order to guarantee their rights.

Uruguay approved vaccination for young people between the ages of 12 and 18 at the beginning of June and, after the United States’ authorization to vaccinate children with Pfizer, it was expected that the South American country would follow the same path.

The South American country accumulates 398,213 total cases since the health emergency was declared on March 13, 2020 due to the detection of the first four infections.

See also  A high circulation of the virus among hairdressers and in education? - Economic policy

Of this total, 1,958 are people who are suffering from the disease and 15 of them are in intensive care centers (ICU) and 6,116 died.

Regarding vaccination, according to the web monitor developed by the Ministry of Public Health (MSP) until 3:26 p.m. (6:26 p.m. GMT) this Wednesday, 2,641,011 people (74.54% of the population) completed their schedule of immunization of the Chinese pharmaceutical companies Sinovac, the Anglo-Swedish AstraZeneca and the American Pfizer.

In addition, 136,655 people were inoculated with only the first dose, while 1,311,256 received a third dose according to the plan announced by this body for those who – after being immunized with Coronavac or AstraZeneca – choose to receive a booster, in this case from Pfizer. EFE


© EFE 2021. The redistribution and redistribution of all or part of the contents of Efe’s services is expressly prohibited, without the prior and express consent of the EFE SA Agency.